题名 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study | 链接 | https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30369-1/abstract |
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30369-1/abstract |